Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma
改良版恩福妥单抗不符合入组标准(mEVITA)在晚期尿路上皮癌中的疗效
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-09806-1
Fukushima, Takafumi; Numakura, Kazuyuki; Shinohara, Masanao; Kawashima, Yohei; Sekine, Yuya; Mori, Kanami; Kobayashi, Mizuki; Asanuma, Himawari; Ichiyama, Takaki; Sakurai, Hisashi; Ozaki, Kai; Fujita, Naoki; Okamoto, Teppei; Yamamoto, Hayato; Yoneyama, Takahiro; Sato, Satoshi; Habuchi, Tomonori; Ohyama, Chikara; Hatakeyama, Shingo